We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+7.4%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$9.77B
AUM Growth
+$1.3B
Cap. Flow
+$764M
Cap. Flow %
7.83%
Top 10 Hldgs %
16.04%
Holding
2,679
New
514
Increased
162
Reduced
972
Closed
72

Sector Composition

Rank Sector Weight
1 Technology 16.73%
2 Financials 15.03%
3 Healthcare 13.46%
4 Industrials 10.27%
5 Consumer Discretionary 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWBI icon
1676
Smith & Wesson
SWBI
$643M
$398K ﹤0.01%
33,354
CSW
1677
CSW Industrials
CSW
$5.59B
$396K ﹤0.01%
7,377
EBSB
1678
DELISTED
Meridian Bancorp, Inc.
EBSB
$396K ﹤0.01%
23,292
TRUP icon
1679
Trupanion
TRUP
$1.36B
$396K ﹤0.01%
11,074
NHC icon
1680
National Healthcare
NHC
$3.44B
$395K ﹤0.01%
5,246
JAG
1681
DELISTED
Jagged Peak Energy Inc.
JAG
$395K ﹤0.01%
28,571
COBZ
1682
DELISTED
CoBiz Financial,Inc
COBZ
$395K ﹤0.01%
17,832
AVX
1683
DELISTED
AVX Corporation
AVX
$395K ﹤0.01%
21,871
CKH
1684
DELISTED
Seacor Holdings Inc.
CKH
$394K ﹤0.01%
7,977
EXTN
1685
DELISTED
Exterran Corporation
EXTN
$394K ﹤0.01%
14,849
RMAX icon
1686
RE/MAX Holdings
RMAX
$265M
$394K ﹤0.01%
8,877
CNS icon
1687
Cohen & Steers
CNS
$4.4B
$394K ﹤0.01%
9,693
TAHO
1688
DELISTED
Tahoe Resources Inc
TAHO
$393K ﹤0.01%
140,851
-2,858
-2% -$11.1K
KPTI icon
1689
Karyopharm Therapeutics
KPTI
$45.1M
$392K ﹤0.01%
1,536
MTSI icon
1690
MACOM Technology Solutions
MTSI
$23.5B
$391K ﹤0.01%
18,984
HAFC icon
1691
Hanmi Financial
HAFC
$963M
$390K ﹤0.01%
15,681
XOXO
1692
DELISTED
Xo Group Inc
XOXO
$390K ﹤0.01%
11,305
FRPT icon
1693
Freshpet
FRPT
$3.5B
$390K ﹤0.01%
+10,616
New +$349K
LGIH icon
1694
LGI Homes
LGIH
$1.37B
$389K ﹤0.01%
8,210
ANGO icon
1695
AngioDynamics
ANGO
$647M
$388K ﹤0.01%
17,852
ADAM
1696
Adamas Trust
ADAM
$907M
$386K ﹤0.01%
15,879
+2,501
+19% +$62.5K
BCRX icon
1697
BioCryst Pharmaceuticals
BCRX
$2.51B
$386K ﹤0.01%
50,588
+7,707
+18% +$51.8K
SYBT icon
1698
Stock Yards Bancorp
SYBT
$2.64B
$386K ﹤0.01%
10,633
RVNC
1699
DELISTED
Revance Therapeutics, Inc.
RVNC
$386K ﹤0.01%
15,532
SP
1700
DELISTED
SP Plus Corporation
SP
$386K ﹤0.01%
10,567

Similar funds

MetLife Investment Management's Q3 2018 Portfolio in Review

As of Q3 2018, MetLife Investment Management held 2,679 positions worth $9.77B, up 15% from $8.47B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

MetLife Investment Management deployed $764M of net new capital in Q3 2018, opening 514 new positions and adding to 162 existing holdings. Its largest new stake was Alphabet (Google) Class C: 1,791,300 shares worth $107M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $23.3M trimmed.

  • MetLife Investment Management's largest Q3 2018 buy was Alphabet (Google) Class C: 1,791,300 shares worth $107M.
  • MetLife Investment Management added most to iShares Core US Aggregate Bond ETF in Q3 2018, an estimated $98.5M increase.
  • MetLife Investment Management's biggest Q3 2018 reduction was Apple, cutting an estimated $23.3M.
  • MetLife Investment Management fully exited Wgl Holdings in Q3 2018, selling an estimated $4.93M.
  • MetLife Investment Management's ten largest holdings make up 16% of its $9.77B portfolio in Q3 2018.
  • MetLife Investment Management opened 514 new positions and closed 72 in Q3 2018.
  • MetLife Investment Management's portfolio value rose 15% quarter-over-quarter to $9.77B.

Based on MetLife Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.